Magstim Group
San Francisco, US · Founded 2015 · Delaware corporation · 1 known investors
Magstim develops neurotechnology and neurostimulation devices for healthcare providers and researchers, focusing on neuromodulation and neurophysiology applications. The company manufactures and supports innovative medical devices used in patient care and neuroscience research globally.
Founders & leadership
Board
TA
Thomas A. RaffinBoard director
JM
J. Matthew MackowskiBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$32.1M disclosed across 1 round · 2015
▶$32.1MraisedOct 2015 · 2 investors · OtherRule 506(b)
▶$32.1MraisedOct 2015 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Thomas A. RaffinExecutive Officer, Director
- J. Matthew MackowskiExecutive Officer, Director
- Offering amount
- $32.1M
- Amount sold
- $32.1M
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
neurocare group68 shared keywordsneurocare group operates a network of over 20 clinics across Europe, the United States, and Australia offering personalized mental health treatments such as TMS, neurofeedback, and tDCS for conditions including depression, ADHD, OCD, and sleep disorders. It also provides a Digital Therapy Platform and an online academy that trains third-party clinicians in its treatment protocols.
Brainsway52 shared keywordsBrainsWay develops Deep TMS (Transcranial Magnetic Stimulation) systems for treating psychiatric and neurological conditions including depression, OCD, and smoking addiction. The platform includes brain-targeting stimulators with patented H-Coils, patient management capabilities, and clinical research-grade variants for healthcare providers.
Neuronetics36 shared keywords
Companies competing with Magstim Group for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Magstim Group do?
- Magstim develops neurotechnology and neurostimulation devices for healthcare providers and researchers, focusing on neuromodulation and neurophysiology applications. The company manufactures and supports innovative medical devices used in patient care and neuroscience research globally.
- Who are Magstim Group's investors?
- Magstim Group's investors include Telegraph Hill Partners.
- How much funding has Magstim Group raised?
- Magstim Group has disclosed $32.1M raised across 1 round.
- Where is Magstim Group headquartered?
- Magstim Group is headquartered in San Francisco, US.